Nature Examines Future Of AMFm

“Although no official decision has been announced about whether to continue the … Affordable Medicines Facility-Malaria (AMFm), many of those familiar with it have told Nature that it must change or be phased out after this year,” the magazine reports in an article examining the future of the pilot program that distributes malaria drugs in seven African countries. “The AMFm aims to make artemisinin-based combination therapies (ACTs) readily available and affordable in malaria-ridden countries by relying on the free market for their distribution,” but “it is unclear how many of the drugs reached the pilot program’s target populations,” Nature writes. The magazine describes possible options for the program, and notes the Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria will recommend a future path for the program at its meeting next month (Maxmen, 10/2).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.